Clinical Trials in San Antonio

Showing 2901-2920 of 12,572 trials

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

NCT07122700

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory qualification of blood- and imaging-based biomarkers to diagnose and stage Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH). MASH is characterized by liver inflammation accompanied by simultaneous fat accumulation in the liver.

Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more

Foundation for the National Institutes of Health400 participantsStarted May 2025

Miami, Florida, United States • Columbus, Ohio, United States • Bellaire, Texas, United States +1 more locations

Enrolling By Invitation< 1 mile

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

NCT06208878

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

Hematologic MalignancySolid Malignancy

CRISPR Therapeutics AG70 participantsStarted Nov 2023

Duarte, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Find Trials by Condition in San Antonio

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Treatment for PTSD and Tinnitus

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Topical ENS-002 for Atopic Dermatitis in Adults

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Expanded Access of Sotorasib

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors